AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial
#1PRI RANKED
Most Cited Paper
in Virus-based gene therapy research
18 Months Post-Publication
Class of 2026
“AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026/
Topics
AAV1 vector · hOTOF gene · OTOFERLIN protein · DFNB9 · DFNB9 · gene therapy · single-arm trial · sensorineural hearing loss · inner ear gene delivery · cochlear hair cells · synaptic vesicle fusion · auditory synapse · hearing restoration
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Virus-based gene therapy research Papers, Class of 2026. https://pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026. Accessed 2026-07-20. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459